HEMPFLAVIN Clinical Study And Effect on Acute and Chronic Pain Patients

Published: March 28, 2022, 4:36 p.m.

Dr. Donato Borrillo and Brian Dickerson, the CEO of Doctor\u2019s Hemp Solutions discuss a new clinical study on HEMPFLAVIN and its effect on acute and chronic pain patients, with zero side effects.

HEMPFLAVIN, a proprietary blend of\xa0twenty-three (23) Cannflavins and flavonoids\xa0extracted from an heirloom\xa0hemp variety which\xa0is over 2,000 years old, is formulated to be used for severe body aches, muscle soreness and other pain relief by creating a synergistic flavonoid response known as the \u201cflavonoid entourage effect\u201d. The flavonoids in HEMPFLAVIN\xa0include Cannflavin A, B, & C, Cannabisin A, B & C, quercetin, apigenin-7- and kaempferol. Previous studies have found that the flavonoids in HEMPFLAVIN have prominent anti-inflammatory action and may help augment the body\u2019s\xa0antioxidant defense.\xa0

The new clinical study conducted by\xa0Dr. Donato Barrillo focused on the effect of flavonoids, specifically the\xa0Cannflavins, which make up less than 0.15% of the fresh weight of cannabis.\xa0To date, a massive amount of cannabis would\xa0have to be consumed in order\xa0for the effects of this component to take place; however, a proprietary extraction\xa0technique has resulted in the production of HEMPFLAVIN, with microgram\xa0quantities\xa0dosing thereby producing an observable clinical effect.

For more information, visit\xa0http://www.hempflavin.com/\xa0and\xa0https://www.doctorshempsolutions.com.